Music |
Video |
Movies |
Chart |
Show |
Intellia Therapeutics CRISPR Genome Editing Treatment for ATTR (Amyloidosis Support Groups) View | |
Intellia CEO on Crispr gene-editing treatment, secondary offering (CNBC Television) View | |
Intellia and the #NewEraOfMedicine (in vivo CRISPR) (The Sheekey Science Show) View | |
Gene Editing Stocks Are Set to Explode. Here's Why. (Nanalyze) View | |
Intellia Stock vs CRISPR Stock: The Winner Is (Nanalyze) View | |
Intellia Therapeutics provide promising interim update on in-vivo CRISPR gene editing NTLA-2001 (HealthWealth) View | |
Intellia Therapeutics: MASSIVE Opportunity in CRISPR - $NTLA Full Analysis (Zoomer Value Investor) View | |
Intellia is the leading CRISPR company (CRISPR Hassan) View | |
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | Journal club (Renal Genetics Education, brought to you by Natera) View | |
Intellia Therapeutics (Alliance for Regenerative Medicine) View |